Lipidome in colorectal cancer

Guifang Yan; Liqi Li; Bo Zhu; Yongsheng Li

doi:10.18632/oncotarget.7960

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Lipidome in colorectal cancer

Guifang Yan, Liqi Li, Bo Zhu and Yongsheng Li _

PDF | HTML | How to cite

Oncotarget. 2016; 7:33429-33439. https://doi.org/10.18632/oncotarget.7960

Metrics: PDF 5121 views | HTML 5166 views | ?

Abstract

Guifang Yan1,*, Liqi Li2,*, Bo Zhu1 and Yongsheng Li1,3

1 Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China

2 Department of General Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, China

3 Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

* These authors contributed equally to this work

Correspondence to:

Bo Zhu, email:

Yongsheng Li, email:

Keywords: lipidome, metabolism, colorectal cancer, fatty acid, cholesterol

Received: December 07, 2015 Accepted: February 25, 2016 Published: March 07, 2016

Abstract

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths. Understanding its pathophysiology is essential for developing efficient strategies to treat this disease. Lipidome, the sum of total lipids, related enzymes, receptors and signaling pathways, plays crucial roles in multiple cellular processes, such as metabolism, energy storage, proliferation and apoptosis. Dysregulation of lipid metabolism and function contributes to the development of CRC, and can be used towards the evaluation of prognosis. The strategies targeting lipidome have been applied in clinical trails and showed promising results. Here we discuss recent advances in abnormal lipid metabolism in CRC, the mechanisms by which the lipidome regulates tumorigenesis and tumor progression, and suggest potential therapeutic targets for clinical trials.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7960

Publication Alerts

Reviews:

Lipidome in colorectal cancer

Abstract